These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 32612233)

  • 1. Clinical targeting of HIV capsid protein with a long-acting small molecule.
    Link JO; Rhee MS; Tse WC; Zheng J; Somoza JR; Rowe W; Begley R; Chiu A; Mulato A; Hansen D; Singer E; Tsai LK; Bam RA; Chou CH; Canales E; Brizgys G; Zhang JR; Li J; Graupe M; Morganelli P; Liu Q; Wu Q; Halcomb RL; Saito RD; Schroeder SD; Lazerwith SE; Bondy S; Jin D; Hung M; Novikov N; Liu X; Villaseñor AG; Cannizzaro CE; Hu EY; Anderson RL; Appleby TC; Lu B; Mwangi J; Liclican A; Niedziela-Majka A; Papalia GA; Wong MH; Leavitt SA; Xu Y; Koditek D; Stepan GJ; Yu H; Pagratis N; Clancy S; Ahmadyar S; Cai TZ; Sellers S; Wolckenhauer SA; Ling J; Callebaut C; Margot N; Ram RR; Liu YP; Hyland R; Sinclair GI; Ruane PJ; Crofoot GE; McDonald CK; Brainard DM; Lad L; Swaminathan S; Sundquist WI; Sakowicz R; Chester AE; Lee WE; Daar ES; Yant SR; Cihlar T
    Nature; 2020 Aug; 584(7822):614-618. PubMed ID: 32612233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model.
    Yant SR; Mulato A; Hansen D; Tse WC; Niedziela-Majka A; Zhang JR; Stepan GJ; Jin D; Wong MH; Perreira JM; Singer E; Papalia GA; Hu EY; Zheng J; Lu B; Schroeder SD; Chou K; Ahmadyar S; Liclican A; Yu H; Novikov N; Paoli E; Gonik D; Ram RR; Hung M; McDougall WM; Brass AL; Sundquist WI; Cihlar T; Link JO
    Nat Med; 2019 Sep; 25(9):1377-1384. PubMed ID: 31501601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lenacapavir: a first-in-class HIV-1 capsid inhibitor.
    Dvory-Sobol H; Shaik N; Callebaut C; Rhee MS
    Curr Opin HIV AIDS; 2022 Jan; 17(1):15-21. PubMed ID: 34871187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
    Marcelin AG; Charpentier C; Jary A; Perrier M; Margot N; Callebaut C; Calvez V; Descamps D
    J Antimicrob Chemother; 2020 Jun; 75(6):1588-1590. PubMed ID: 32154864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.
    Sun L; Zhang X; Xu S; Huang T; Song S; Cherukupalli S; Zhan P; Liu X
    Eur J Med Chem; 2021 May; 217():113380. PubMed ID: 33751981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
    Thenin-Houssier S; Valente ST
    Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
    Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV capsid is a tractable target for small molecule therapeutic intervention.
    Blair WS; Pickford C; Irving SL; Brown DG; Anderson M; Bazin R; Cao J; Ciaramella G; Isaacson J; Jackson L; Hunt R; Kjerrstrom A; Nieman JA; Patick AK; Perros M; Scott AD; Whitby K; Wu H; Butler SL
    PLoS Pathog; 2010 Dec; 6(12):e1001220. PubMed ID: 21170360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsid proteins of enveloped viruses as antiviral drug targets.
    Klumpp K; Crépin T
    Curr Opin Virol; 2014 Apr; 5():63-71. PubMed ID: 24607800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
    Shi J; Zhou J; Shah VB; Aiken C; Whitby K
    J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
    Zhou J; Price AJ; Halambage UD; James LC; Aiken C
    J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent.
    Subramanian R; Tang J; Zheng J; Lu B; Wang K; Yant SR; Stepan GJ; Mulato A; Yu H; Schroeder S; Shaik N; Singh R; Wolckenhauer S; Chester A; Tse WC; Chiu A; Rhee M; Cihlar T; Rowe W; Smith BJ
    Mol Pharm; 2023 Dec; 20(12):6213-6225. PubMed ID: 37917742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microplate-based assay for identifying small molecules that bind a specific intersubunit interface within the assembled HIV-1 capsid.
    Halambage UD; Wong JP; Melancon BJ; Lindsley CW; Aiken C
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5190-5. PubMed ID: 26077250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
    Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
    Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Dynamics Free Energy Simulations Reveal the Mechanism for the Antiviral Resistance of the M66I HIV-1 Capsid Mutation.
    Sun Q; Levy RM; Kirby KA; Wang Z; Sarafianos SG; Deng N
    Viruses; 2021 May; 13(5):. PubMed ID: 34063519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir.
    Bester SM; Adu-Ampratwum D; Annamalai AS; Wei G; Briganti L; Murphy BC; Haney R; Fuchs JR; Kvaratskhelia M
    mBio; 2022 Oct; 13(5):e0180422. PubMed ID: 36190128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.